Kristen Aufiero

发表

337 Intratumoral immune therapy for recurrent breast cancer with polyICLC, and tremelimumab combined with systemic durvalumab

I. Puzanov, C. Slingluff, P. Friedlander, 2021, Journal for ImmunoTherapy of Cancer.